Skip to content

Investigating the Effect of Erector Spinae Plane Block during Posterior Cervical Spine Fusion Surgery with Lateral Mass Fixation on Postoperative Axial Pain

Investigating the Effect of Erector Spinae Plane Block during Posterior Cervical Spine Fusion Surgery with Lateral Mass Fixation on Postoperative Axial Pain

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230504058083N1
Enrollment
60
Registered
2023-10-15
Start date
2023-09-23
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

???? ????? ????. Connective tissue stenosis of neural canal of cervical region

Interventions

Intervention 1: Intervention group: A group of 30 people receive 4 milligrams of dexamethasone and 15 cc of 0.5% bupivacaine (maximum injectable dose of bupivacaine for local injection is 175 milligra

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: no preoperative lower limb palsy no lower limb paralysis that would impede the patient's ability to walk no addiction to drugs (except for smoking) that would interfere with pain assessment non-pregnancy absence of a severe concurrent illness that would interfere with the investigation of the cause of pain no obstructive cardiac disease no acute neck trauma patient's full consent to participate in the study age between 18 and 65 years fusion in the C3-C7 range no sickle cell disease in the patient no sensitivity to epinephrine and anesthetics no underlying cancer

Exclusion criteria

Exclusion criteria: pregnancy a significant drop in lower limb force after the surgery that would impede the patient's ability to walk after the operation acute neck trauma any accompanying illness that would interfere with the investigation of the cause of pain any concurrent surgery outside the C3-C7 range infection at the surgical site up to one week after the operation age below 18 years and above 65 years a severe diagnosed psychiatric illness or a psychiatric illness that the patient is taking medication for or has a history of taking medication to treat if the patient has a gain If the patient undergoes simultaneous neck surgery through the anterior approach addiction to drugs (except for smoking) if the reason for the surgery is a tumor

Design outcomes

Primary

MeasureTime frame
Postoperative pain intensity. Timepoint: 6 hours, 24 hours, 48 hours, and 1 week after surgery. Method of measurement: Numeric Rating Scale score.;Amount of narcotic analgesic consumption. Timepoint: 24 hours and 48 hours after surgery. Method of measurement: The dose of injected narcotic medication is recorded in milligrams in the documents included in the file during 24 and 48 hours after the end of the surgery.;Type of analgesic used. Timepoint: 24 hours and 48 hours after surgery. Method of measurement: Investigating the type of medication injected based on the documents included in the file during 24 and 48 hours after the end of the surgery.;The first time the patient walks after surgery. Timepoint: Up to 48 hours after surgery. Method of measurement: The duration from the end of surgery until the patient starts walking in the ward, as observed directly and asked from the patient.;The first time the patient requests pain medication. Timepoint: Up to 48 hours after surgery. Method of measurement: The time from the end of surgery until the patient requests pain medication for pain relief, recorded in hours with the help of patient questioning.;Number of cervical fusion levels. Timepoint: At the end of the surgical procedure. Method of measurement: The number of cervical vertebrae that have screws inserted into them is recorded through direct observation of radiology images taken after the surgery.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Rostami Ravari

Tehran University of Medical Sciences

dmr.rostami@gmail.com+98 21 8490 1000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026